Lilly(Eli) & Company
NYSE: LLY
$794.14
-$1.53 (-0.2%)
Closing Price on December 26, 2024
LLY Articles
This trading week has been shorter than most with Thanksgiving taking place on Thursday. As a result not too many companies have released news, updates or earnings this week, despite the markets...
Published:
Last Updated:
Eli Lilly & Co. (NYSE: LLY) is watching its shares in free fall on Wednesday, not from any election or political concerns but a late-stage trial failure. As we have said time and again, clinical...
Published:
Last Updated:
Now is a good time to add quality stocks in front of what is usually a very good time of the year for equities. These four stocks offer investors solid upside potential.
Published:
Last Updated:
The analysts at Merrill Lynch have made a big move by adding a top property and casualty company to the firm's well-respected US 1 list of stocks to Buy.
Published:
Last Updated:
The recent headlines and the huge Trump following have helped closed the gap on Clinton, and if Trump is declared the winner, we could see a large market drop next week.
Published:
Last Updated:
The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income investors have a chance to buy some great stocks on sale.
Published:
Last Updated:
A UBS research report notes the segments of the economy that may disproportionately benefit as all the money that baby boomers had stashed away in savings, pensions, IRAs and 401(k) plans starts to...
Published:
Last Updated:
Eli Lilly plans to release its most recent earnings report before the markets open on Tuesday, and analysts expect top and bottom line growth.
Published:
Last Updated:
Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even — for many biotech companies in the depression space.
Published:
Last Updated:
A recent Merrill Lynch research features a big move by adding a top consumer goods company to the firm's well-respected US 1 list.
Published:
Last Updated:
A new Jefferies research report features top pharmaceutical picks for the fourth quarter. Any of these top picks make good sense for long-term growth and income portfolios.
Published:
Last Updated:
One smart thing for growth stock buyers is to focus on total return and buy large cap quality stocks that will do well regardless of the near-term economic news.
Published:
Last Updated:
Eli Lilly shares had a bit of a boost on Wednesday after it was announced that one of its subsidiaries would be acquiring Boehringer Ingelheim Vetmedica.
Published:
Last Updated:
A recent Merrill Lynch research report features the firm's top ideas for the fourth quarter. These eight stocks look like outstanding picks for growth stock accounts.
Published:
Last Updated:
Any of these three top pharmaceutical companies makes an outstanding addition to more conservative portfolios. They are also far less volatile and act better than biotechs if the market gets dicey.
Published:
Last Updated: